NEWS

AmCham Norway Healthcare Position Paper

Category: AmCham News

AmCham Norway’s Healthcare Working Group – comprised of directors of the leading international pharmaceutical companies in the country – works to improve Norwegian patients’ access to the most effective, innovative, and timely treatments available. The working group contributes to a wide range of healthcare policy discussions, providing policymakers and relevant stakeholders with genuine industry information and insight. This position paper summarizes the group’s positions on healthcare innovation, market access, and the pursuit of enhanced collaboration with the public sector, positions that reflect the group’s unyielding commitment to improving patient outcomes and building an improved, more sustainable healthcare system in Norway.

Source: AmCham

Arendalsuka 2019 Summary

Category: AmCham News

There are few things better than the excitement and passion of Arendalsuka, and AmCham made the trek down to southern Norway again this year to put on an exciting program of healthcare-related events featuring a diverse array of industry leaders and politicians.

Source: AmCham

AmCham deltar i Stortingets Helsekomite-høring

Category: AmCham Norway

— AmCham ser ingen grunn til at det skal være ulikt for offentlige anskaffelser av legemidler i forhold til anskaffelser i andre sektorer, eller helsesektoren for øvrig, sa Katja Dahl Murphy, Myndighetskontakt i AmCham Norway, på høringen om konfidensielle legemiddelpriser i regi av Stortingets Helse- og omsorgskomite tidligere i dag (torsdag). — Konfidensialitet rundt enhetspriser […]

Source: AmCham

AmCham’s Arendalsuka Debate: The Pharmaceutical Industry Revealed

Category: AmCham News

According to data from Apeland and Norstat, only 5% of the population in Norway considers the pharmaceutical industry to be trustworthy, with only 52% of Norwegian survey respondents reporting any familiarity with the industry at all. With these statistics as a starting point, a panel consisting of senior representatives from the pharmaceutical industry, politicians and […]

Source:

Vi i legemiddelindustrien må fortelle folk hva vi gjør

Category: Healthcare

Representanter fra legemiddelindustrien og politikken diskuterte omdømmeproblematikk og legemiddelpriser på Arendalsuka 2018. ARENDAL: American Chamber of Commerce in Norway (AmCham Norway) arbeider for å bygge og opprettholde norske og amerikanske forretningsforbindelser. På Arendalsuka 2018 arrangerte de møtet «The Pharmaceutical Industry revealed: who, what, why and when?». Et av hovedtemaene som ble brakt på banen var […]

Source: Norsk Farmaceutisk Tidsskrift

Published: April 9, 2020